Depression in Alzheimer's Disease-2

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Alzheimer's Disease, Depression

In brief

The purpose of this study is to learn whether treating individuals with Alzheimer's disease and depression with the anti-depressant medication sertraline (Zoloft) is helpful to people with Alzheimer's disease and to their families and caregivers.

Key facts

Study ID

NCT00086138

Run by

Johns Hopkins University

People needed

131

Starts

2004-07-01

Expected to finish

2009-07-01

Last updated by the study team

2017-04-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Southern California — Los Angeles, California, United States
• Johns Hopkins Hospital — Baltimore, Maryland, United States
• University of Rochester — Rochester, New York, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Medical University of South Carolina — North Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.